Cannabis users show better folate levels than other drug users

This study examined folate deficiency patterns across 633 patients with substance use disorders, comparing four groups: alcohol users, cannabinoid users, methamphetamine users, and opioid users. The researchers found significant differences in folate levels and deficiency rates depending on which substance was being used. Folate, a critical B vitamin, plays an important role in cell division, DNA synthesis, and neurological function—all processes that are particularly vulnerable in people struggling with substance use disorders.

The research revealed that methamphetamine users had the lowest folate levels and the highest rates of possible folate deficiency, compared to the other groups. Notably, cannabinoid users showed significantly better folate status than alcohol, methamphetamine, and opioid users. This suggests that cannabis use may not be as directly associated with folate depletion as these other substances, which is relevant for understanding the comparative health impacts of different drugs of abuse.

The study's key takeaway is that nutritional interventions—specifically folic acid supplementation and improved nutrition—could play an important supporting role in recovery programs for substance use disorders, especially for methamphetamine, alcohol, and opioid users. For cannabinoid users specifically, the relatively preserved folate status suggests different metabolic impacts compared to other commonly abused substances, though addressing overall nutritional health remains important for all substance use disorder patients during recovery.